Supply chain, logistics

Competitors race to launch GLP-1 drugs amid soaring weight loss demand

31-Oct-2024 By Clara Rodriguez Fernandez

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are the companies racing for approval of their own versions of these highly coveted drugs.

Boosting pharma security: Systech's track and trace tech

14-Aug-2024 By Liza Laws

In the fight against counterfeit pharmaceuticals, Systech stands at the forefront with its advanced track and trace technology.

How nuVizz transforms pharma supply chains: Insights from its CEO, Guru Rao

14-Aug-2024 By Liza Laws

In the ever-evolving world of pharmaceutical logistics, nuVizz has emerged as a key player, delivering innovative solutions that streamline the delivery management process.

Improving clinical supply chains: An in-depth conversation with IQVIA's Stefan Duerr

14-Aug-2024 By Liza Laws

In the intricate world of clinical trials, the integrity and efficiency of the drug supply chain are paramount.

FDA approves Rusan Pharma’s manufacturing facility in India, paving the way for expanded US presence

23-Jul-2024 By Liza Laws

Rusan Pharma Private Limited has announced that its active pharmaceutical ingredient (API) manufacturing facility in Ankleshwar, Gujarat, has been granted Good Manufacturing Practice (GMP) approval by the FDA.

Blow-fill-seal technology: Realizing a new frontier in sterile packaging

12-Jul-2024 By Liza Laws

Blow-fill-seal (BFS) technology has long been a cornerstone of pharmaceutical manufacturing, relied on for packaging sterile liquid medications, including but not limited to ophthalmic and respiratory drug products.

The top 5 emerging startups fuelling drug discovery with AI

27-Jun-2024 By Liza Laws

Artificial intelligence is showing great promise in the quest to unearth new drug candidates and disease targets faster than ever before.

Systech unveils game-changing turnkey solution for pharma rework and aggregation

10-Jun-2024 By Liza Laws

In a groundbreaking development, Systech, a subsidiary of Markem-Imaje and Dover, has introduced a turnkey manual aggregation and rework solution tailored for pharmaceutical manufacturers, CMOs, CDMOs, re-packagers, and wholesalers.

Pluss unveils Celsure XL VIP pallets - a game-changer for the pharma industry?

03-Apr-2024 By Liza Laws

Pluss, a leading provider of temperature-controlled packaging solutions, today (April 3) launched its latest innovation, the Celsure XL VIP pallets.

Two new purpose-built facilities built for Almac Group in Northern Ireland to meet growing demand

06-Mar-2024 By Liza Laws

Almac Group, a global leader in CDMOs, announced today (March 6) that it has unveiled two new purpose-built facilities at its headquarters in Northern Ireland.

Phesi's huge repository of data in its Trial Accelerator platform reaches 100 million milestone

06-Feb-2024 By Liza Laws

Phesi’s artificial intelligence (AI) driven platform, Trial Accelerator, has reached a milestone and now contains global data from more than 100 million patients.

Tola Olorunnisola tells women to dare themselves to try - and to never underestimate their skills

17-Jan-2024 By Liza Laws

Tola Olorunnisola is currently senior vice president, clinical services & strategy at Avantor and along with her team is working on delivering digital innovations in the lab.

Cormica Bradford expanding equipment range to update capabilities

15-Jan-2024 By Liza Laws

Cormica Bradford, a division of Cormica says it is proud to announce a significant expansion of its laboratory capabilities.

SGD Pharma to grow significantly in 2024 with investments and package manufacturing

15-Jan-2024 By Liza Laws

SGD Pharma has announced its goal to become the global market leader in primary pharmaceutical glass packaging.

CPHI South East Asia visitor numbers expected to double as interest in drug supply chain security booms

06-Jul-2023 By Liza Laws

This year’s CPHI South East Asia is expecting a surge in international partnering with organizers expecting a record attendance of 8,000 visitors including a significant number from overseas – doubling last year’s figures.

Genixus adds manufacturing facility for syringe production

16-Mar-2023 By Ben Hargreaves

The company will build out a manufacturing, warehousing, and distribution center in the US to expand capacity for syringes.

Assentia launches tech platforms to support payments in the clinical trial space

14-Mar-2023 By Ben Hargreaves

The company releases two SaaS-based applications, GrantPay and GrantPact, to provide clinical trial contract negotiation and payment services.

EQRx backtracks on plans to reduce pricing of lead cancer treatments

21-Nov-2022 By Ben Hargreaves

For its two lead oncology programs, the company will pursue “market-based pricing”, moving away from plans to “dramatically lower prices” for treatments.

Medisca announces plans for distribution and packaging center

07-Nov-2022 By Ben Hargreaves

The facility will comprise of a standalone building to consolidate repackaging and distribution operations in the state of New York, US.

McKesson opens largest distribution facility in its network

03-Nov-2022 By Ben Hargreaves

The company officially unveils its pharmaceutical distribution center that is based in Jeffersonville, Ohio.

CPHI Pharma Award finalists announced

26-Oct-2022

The awards cover innovations spanning the full pharmaceutical supply chain and feature many of pharma’s biggest names and breakthrough companies.

Industry body points to ‘clear and serious threat’ to clinical research in UK

26-Oct-2022 By Ben Hargreaves

The ABPI releases a report that shows the number of clinical trials taking place in the UK fell by a large amount between the years 2017 and 2021.

FDA announces Adderall supply has been hit by manufacturing issues

18-Oct-2022 By Ben Hargreaves

According to the agency, Teva communicated that it would have difficulties supplying immediate release formulations of the drug due to manufacturing delays.

Gilead takes legal fight to ‘kingpins’ of counterfeit HIV medicine

04-Oct-2022 By Ben Hargreaves

The company announces further measures against a counterfeiting network it accused of being responsible for selling illegitimate Gilead HIV medications.

Takeda signs 12-year renewable energy agreement in US

26-Sep-2022 By Ben Hargreaves

Adding to broader action being taken across the industry, the company has signed an agreement with Enel for the supply of renewable energy credits covering its electricity needs across the US.

Market demands, trends impacting APIs and excipients: MilliporeSigma

31-Aug-2022 By Jenni Spinner

An expert from the company discusses how ever-changing patient needs and other dynamic factors are likely to impact pharma ingredient trends down the road.

Synthetic bio company Antheia raises $40m, announces new pilot plant

31-Aug-2022 By Jenni Spinner

The synthetic biology company which specializes in producing ingredients for plant-inspired medicines has a pilot-scale manufacturing facility in the works.

New WuXi STA plant to tackle growing HPAPI demand

31-Aug-2022 By Jenni Spinner

A company leader advises that the growing need for high-potency active pharmaceutical ingredients calls for CDMOs that consistently deliver quality at scale.

Outsourcing strategists thinking farther ahead than ever: CPHI

23-Aug-2022 By Jenni Spinner

The group’s latest report glimpses inside the minds of pharma leaders, who are looking at a product’s full life-cycle development at the preclinical stage.

Tech Innovations: August 2022

22-Aug-2022 By Jenni Spinner

This month’s news on technology, partnerships, expansions, and more includes items from IQVIA, Almac Group, Signant Health, Lonza, and other key companies.

Signant turns to Loftware for clinical supply chain management support

15-Aug-2022 By Nick Taylor

Signant Health has partnered with the software company o connect its platforms for the management of clinical supply chain inventory, labels, and content.

UPS acquires multi-national healthcare logistics company Bomi

15-Aug-2022 By Jenni Spinner

The purchase brings under the UPS Healthcare umbrella several temperature-controlled facilities in 14 countries situated throughout Europe and Latin America.

Novasep-PharmaZell commits nearly$7.5m to boosting API capacity

01-Aug-2022 By Jenni Spinner

The contract development and manufacturing organization plans to invest €7.3m to expand and upgrade API production capacity at its Mourenx, France facility.

Will biotech see an uptick in M&A?

19-Jul-2022 By Rachel Arthur

The biopharma M&A market has slowed since 2019. But is a buyer’s market emerging?

Piramal Pharma Solutions opens doors on API production plant

13-Jul-2022 By Jenni Spinner

The contract development and manufacturing organization's active pharmaceutical ingredient manufacturing operation is located at its site in Aurora, Canada.

Vetter kicks off operations at fill-and-finish facility in Austria

13-Jul-2022 By Jenni Spinner

The contract development and manufacturing organization has begun fulfilling customer orders at its new clinical manufacturing facility in Rankweil, Austria.

On-demand cleanrooms help pharma manufacturers ‘fail fast’

13-Jul-2022 By Jenni Spinner

A representative from life-science services company Azzur Group explains how flexibility and speed can help in reaching the best solution more efficiently.

People on the Move: July 2022

11-Jul-2022 By Jenni Spinner

This month’s announcements of launches, appointments, and partnerships includes Saama, COTA, Yourway, Eversana, Kindeva, and other notable industry companies.

Building resilience into biotech supply chains: 'COVID-19 will not be the last major crisis of the 21st century'

08-Jul-2022 By Rachel Arthur

Biotech supply chains face an uncertain future in 2022 and beyond: up against myriad challenges ranging from future pandemic outbreaks to geopolitical tensions – and, indeed, unforeseen threats. Communication and collaboration between policymakers and...

EY biotech report checks in on the mood of industry leaders

23-Jun-2022 By Jenni Spinner

The 32nd iteration of the company’s Beyond Borders report offers an in-depth look at the state of the current market landscape, and what’s on the horizon.

BIO research outlines risks in changing accelerated approval pathway

21-Jun-2022 By Rachel Arthur

If new restrictions are placed on the FDA’s Accelerated Approval pathway, as many as two thirds of the treatments that use this pathway would never reach patients, according to research released at the BIO International Convention last week.

Tech Innovations: June 2022

16-Jun-2022 By Jenni Spinner

This month’s announcements on new products, enhanced technology, partnerships, and more includes Eversana, Thermo Fisher Scientific, and other notable companies.

bio 2022

Pandemic highlights need for supply chain visibility, partnerships

14-Jun-2022 By Jenni Spinner

During BIO International, US leaders shared lessons learned from COVID-19, and how government and industry are collaborating to avoid future supply chain crises.

bio 2022

ten23 adds manufacturing building in rapid build out

14-Jun-2022 By Ben Hargreaves

The newly launched CDMO plans to set up two new manufacturing lines, after expanding into a 5,000-square-meter manufacturing facility.

dia 2022

Collaboration, innovation to take center stage at DIA 2022

08-Jun-2022 By Jenni Spinner

This year’s DIA Global Annual Meeting (taking place June 19-23 in Chicago) reunites professionals for face-to-face learning and networking opportunities.

Building in resilience can protect against disruption: Rockwell

08-Jun-2022 By Jenni Spinner

An expert from Rockwell Automation explains how integrating flexibility, using advanced technology, can help pharma manufacturing operations weather a storm.

Lilly invests $2.1bn in new Indiana manufacturing sites

31-May-2022 By Rachel Arthur

Eli Lilly and Company plans to expand its manufacturing footprint in Indiana by investing $2.1bn in two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research District in Boone County.

Novartis looks to work more strategically as CDMO

16-May-2022 By Jane Byrne

Novartis has recently set up a new contract development and manufacturing unit called Global Biotech Co-operations (GBTC).

Survey: industry leaders looking to shore up pharma supply chain

05-May-2022 By Jenni Spinner

According to the 2022 EY CEO survey, life science executives are seeking to build resilience into their supply chains and dive into M&A opportunities.

CPHI North America

Future drugs will need novel excipients: IPEC

04-May-2022 By Jenni Spinner

An expert from the organization discusses ahead of his CPhI North America presentation how tomorrow’s drugs can’t all be formulated with yesterday’s excipients.